ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 5 filers reported holding ALBIREO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $341,481 | +4.4% | 15,802 | -6.4% | 0.00% | 0.0% |
| Q3 2022 | $327,000 | -7.4% | 16,883 | -5.1% | 0.00% | 0.0% |
| Q2 2022 | $353,000 | -48.1% | 17,785 | -22.0% | 0.00% | 0.0% |
| Q1 2022 | $680,000 | +28.1% | 22,800 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $531,000 | -42.9% | 22,800 | -23.5% | 0.00% | -50.0% |
| Q3 2021 | $930,000 | -21.3% | 29,800 | -11.3% | 0.00% | 0.0% |
| Q2 2021 | $1,182,000 | +7.5% | 33,600 | +7.7% | 0.00% | 0.0% |
| Q1 2021 | $1,100,000 | -7.2% | 31,200 | -1.3% | 0.00% | -33.3% |
| Q4 2020 | $1,185,000 | +34.0% | 31,600 | +19.2% | 0.00% | +50.0% |
| Q3 2020 | $884,000 | +64.3% | 26,500 | +30.5% | 0.00% | +100.0% |
| Q2 2020 | $538,000 | +97.1% | 20,300 | +21.6% | 0.00% | 0.0% |
| Q1 2020 | $273,000 | -30.7% | 16,700 | +7.7% | 0.00% | 0.0% |
| Q4 2019 | $394,000 | +27.1% | 15,500 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $310,000 | -23.6% | 15,500 | +23.0% | 0.00% | 0.0% |
| Q2 2019 | $406,000 | +2.5% | 12,600 | +2.4% | 0.00% | 0.0% |
| Q1 2019 | $396,000 | +70.0% | 12,300 | +29.5% | 0.00% | 0.0% |
| Q4 2018 | $233,000 | -25.6% | 9,500 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $313,000 | – | 9,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 480,000 | $14,318,000 | 9.25% |
| Decheng Capital Management III (Cayman), LLC | 518,342 | $15,462,000 | 4.74% |
| TANG CAPITAL MANAGEMENT LLC | 467,702 | $13,952,000 | 2.79% |
| Birchview Capital, LP | 113,000 | $3,371,000 | 2.43% |
| Privium Fund Management B.V. | 351,805 | $10,494,000 | 2.32% |
| Sio Capital Management, LLC | 144,546 | $4,312,000 | 1.43% |
| Perceptive Advisors | 2,360,139 | $70,403,000 | 1.41% |
| Chicago Capital, LLC | 1,011,744 | $30,180,000 | 1.30% |
| Endurant Capital Management LP | 120,834 | $3,604,000 | 0.95% |
| Nicholas Investment Partners, LP | 439,235 | $13,102,000 | 0.93% |